Show simple item record

 
dc.contributorDepartament de Salut
dc.contributor.authorArias-de la Torre, Jorge
dc.contributor.authorZioga, Evangelia AM.
dc.contributor.authorMacorigh, Lizza
dc.contributor.authorMuñoz-Ortiz, Laura
dc.contributor.authorEstrada-Cuxart, Oriol
dc.contributor.authorMias, Montse
dc.contributor.authorEstrada-Sabadell, Maria D.
dc.contributor.authorPuigdomenech Puig, Elisa
dc.contributor.authorValderas, Jose M.
dc.contributor.authorMartín, Vicente
dc.contributor.authorMolina, Antonio J.
dc.contributor.authorEspallargues-Carreras, Mireia
dc.date.accessioned2020-06-23T07:21:26Z
dc.date.available2020-06-23T07:21:26Z
dc.date.issued2020-05-13
dc.identifier.citationArias-de la Torre J, Zioga EAM, Macorigh L, Muñoz L, Estrada O, Mias M, et al. Differences in results and related factors between hospital-at-home modalities in Catalonia: a cross-sectional study. J Clin Med. 2020 May 13;9(5):E1461.
dc.identifier.urihttps://hdl.handle.net/11351/5044
dc.descriptionAverage stay; Cross-sectional study; Hospital-at-home; Mortality
dc.description.abstractHospital-at-home (HaH) is a healthcare modality that provides active treatment by healthcare staff in the patient's home for a condition that would otherwise require hospitalization. The aims were to describe the characteristics of different types of hospital-at-home (HaH), assess their results, and examine which factors could be related to these results. A cross-sectional study based on data from all 2014 HaH contacts from Catalonia was designed. The following HaH modalities were considered-admission avoidance (n = 7,214; 75.1%) and early assisted discharge (n = 2,387; 24.9%). The main outcome indicators were readmission, mortality, and length of stay (days). Multivariable models were fitted to assess the association between explanatory factors and outcomes. Hospital admission avoidance is a scheme in which, instead of being admitted to acute care hospitals, patients are directly treated in their own homes. Early assisted discharge is a scheme in which hospital in-care patients continue their treatment at home. In the hospital avoidance modality, there were 8.3% readmissions, 0.9% mortality, and a mean length of stay (SD) of 9.6 (10.6) days. In the early assisted discharge modality, these figures were 7.9%, 0.5%, and 9.8 (11.1), respectively. In both modalities, readmission and mean length of stay were related to comorbidity and type of hospital, and mortality with age. The results of HaH in Catalonia are similar to those observed in other contexts. The factors related to these results identified might help to improve the effectiveness and efficiency of the different HaH modalities.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofseriesJournal of Clinical Medicine;9(5)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectHospitalització domiciliària - Catalunya - Estudi de casos
dc.subject.meshHome Care Services
dc.subject.meshCross-Sectional Studies
dc.subject.meshCatalonia
dc.titleDifferences in results and related factors between hospital-at-home modalities in Catalonia: a cross-sectional study
dc.typeinfo:eu-repo/semantics/article
dc.subject.decsServicios de Atención de Salud a Domicilio
dc.subject.decsestudios transversales
dc.subject.decsCataluña
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.authoraffiliation[Arias-de la Torre J] Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Instituto de Biomedicina (IBIOMED), Universidad de León, León, Spain. [Zioga EAM] Departament de Medicina Interna, Hospital Dos de Maig, Consorci Sanitari Integral, Barcelona, Spain. [Macorigh L] Departament de Medicina Interna, Hospital de Granollers, Granollers, Spain. [Muñoz L] Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Madrid, Spain. [Estrada O] Direcció de Processos Assistencials i Aliances, Gerència Territorial Metropolitana Nord, Institut Català de la Salut (ICS), Barcelona, Spain. [Mias M] Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. [Estrada MD] Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. [Puigdomenech E] Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Madrid, Spain. [Valderas JM] Health Services and Policy Research Group, University of Exeter Medical School, Exeter, UK. [Martín V] CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Instituto de Biomedicina (IBIOMED), Universidad de León, León, Spain. [Molina AJ] Instituto de Biomedicina (IBIOMED), Universidad de León, León, Spain. [Espallargues M] Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Madrid, Spain
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record